Evidence map›Paper›PMID 28301728›Full record

ReviewAnnual review of analytical chemistry (Palo Alto, Calif.)2017

Coupling Front-End Separations, Ion Mobility Spectrometry, and Mass Spectrometry For Enhanced Multidimensional Biological and Environmental Analyses.

Xueyun Zheng, Roza Wojcik, Xing Zhang, Yehia M Ibrahim, Kristin E Burnum-Johnson, Daniel J Orton, Matthew E Monroe, Ronald J Moore, Richard D Smith, Erin S Baker

Abstract readReview
In one paragraph

Review in Annual review of analytical chemistry (Palo Alto, Calif.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xueyun ZhengEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352; email: erin.baker@pnnl.gov.
Roza WojcikEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352; email: erin.baker@pnnl.gov.
Xing ZhangSkaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, University of Colorado, Denver, Colorado 80045.
Yehia M IbrahimEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352; email: erin.baker@pnnl.gov.
Kristin E Burnum-JohnsonEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352; email: erin.baker@pnnl.gov.
Daniel J OrtonEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352; email: erin.baker@pnnl.gov.
Matthew E MonroeEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352; email: erin.baker@pnnl.gov.
Ronald J MooreEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352; email: erin.baker@pnnl.gov.
Richard D SmithEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352; email: erin.baker@pnnl.gov.
Erin S BakerEarth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352; email: erin.baker@pnnl.gov.
Pacific Northwest National Laboratory · USUniversity of Montana · US

Funding

Systems Biology Identifies Restriction Factors for West Nile VirusU19AI106772 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SMITH, RICHARD D · 2013 to 2017
$26.1M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
Platform Providing Increased Throughput, Sensitivity and Specificity for MetaboloR01ES022190 · NIEHS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI BAKER, ERIN S · 2012 to 2016
$2.2M
NIAID NIH HHS U19 AI106772NIEHS NIH HHS R01 ES022190NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

Ion mobility spectrometry (IMS) is a widely used analytical technique for rapid molecular separations in the gas phase. Though IMS alone is useful, its coupling with mass spectrometry (MS) and front-end separations is extremely beneficial for increasing measurement sensitivity, peak capacity of complex mixtures, and the scope of molecular information available from biological and environmental sample analyses. In fact, multiple disease screening and environmental evaluations have illustrated that the IMS-based multidimensional separations extract information that cannot be acquired with each technique individually. This review highlights three-dimensional separations using IMS-MS in conjunction with a range of front-end techniques, such as gas chromatography, supercritical fluid chromatography, liquid chromatography, solid-phase extractions, capillary electrophoresis, field asymmetric ion mobility spectrometry, and microfluidic devices. The origination, current state, various applications, and future capabilities of these multidimensional approaches are described in detail to provide insight into their uses and benefits.

Indexed as

Bacterial ToxinsChromatography, LiquidChromatography, Supercritical FluidEnvironmental MonitoringGasesIonsMass SpectrometryMicrofluidicsPharmaceutical PreparationsBacterial ToxinsGasesIonsPharmaceutical Preparationscapillary electrophoresisdrift tube IMSfield asymmetric ion mobility spectrometrygas chromatographyliquid chromatographymicrofluidicssolid-phase extractionstructure for lossless ion manipulationssupercritical fluid chromatography

Identifiers

PMID28301728
PMCPMC5627998
OpenAlexW2559284283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.